Document Detail


Fixed minidose versus-adjusted low-dose warfarin after total joint arthroplasty: a randomized prospective study.
MedLine Citation:
PMID:  11740759     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Widespread use of adjusted low-dose warfarin has been limited by the inconvenience of outpatient laboratory monitoring and the perceived risk of bleeding complications. We sought to determine if the dose of warfarin could be lowered safely even further, eliminating the need for laboratory monitoring and lowering the complication rate. Two hundred forty-five Patients undergoing primary total joint arthroplasty (n = 245) were randomized prospectively to adjusted low-dose warfarin (international normalized ratio [INR], 1.4-1.8) or fixed minidose warfarin (2 mg daily, regardless of INR) before hospital discharge. Prophylaxis continued for 6 weeks, with twice-weekly laboratory monitoring. Patients were followed for bleeding, thromboembolic events, and minor reported complications of warfarin therapy. With the numbers available, the rates of thromboembolic and bleeding events were not significantly different using equivalence analysis. Of patients in the fixed group, 8% had INRs >3.1, necessitating a decrease in dosage to 1 mg. Although such a fixed-dose protocol may simplify outpatient prophylaxis, intermittent monitoring still would be required because a subset of patients achieve a moderate level of anticoagulation and would be at risk for bleeding complications.
Authors:
M J Vives; W J Hozack; P F Sharkey; L Moriarty; B Sokoloff; R H Rothman
Related Documents :
20598989 - Lowering the intensity of oral anticoagulant therapy in patients with bileaflet mechani...
17654609 - Bleeding complications in skin cancer surgery are associated with warfarin but not aspi...
12957419 - A randomized trial of aspirin on the risk of embolic events in patients with infective ...
11175159 - Management of nonobstructive thrombosis of prosthetic mitral valve in asymptomatic pati...
17263709 - Low-molecular-weight heparin as bridging therapy during interruption of oral anticoagul...
19608549 - State-of-the-art review: assessing the safety profiles of new anticoagulants for major ...
24906869 - Morphological and electrophysiological outcome in prospective intravitreal bevacizumab ...
9426429 - Laparoscopic versus open posterior adrenalectomy: a case-control study of 100 patients.
21604179 - Optimizing fluid management in patients with acute decompensated heart failure (adhf): ...
Publication Detail:
Type:  Clinical Trial; Journal Article; Randomized Controlled Trial    
Journal Detail:
Title:  The Journal of arthroplasty     Volume:  16     ISSN:  0883-5403     ISO Abbreviation:  J Arthroplasty     Publication Date:  2001 Dec 
Date Detail:
Created Date:  2001-12-12     Completed Date:  2002-02-22     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  8703515     Medline TA:  J Arthroplasty     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1030-7     Citation Subset:  IM    
Affiliation:
Department of Orthopaedic Surgery, Jefferson Medical College of Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Anticoagulants / administration & dosage*,  adverse effects
Arthroplasty, Replacement*
Chi-Square Distribution
Female
Humans
International Normalized Ratio
Male
Middle Aged
Postoperative Complications / prevention & control*
Prospective Studies
Prothrombin Time
Pulmonary Embolism / etiology,  prevention & control*
Treatment Outcome
Venous Thrombosis / etiology,  prevention & control*
Warfarin / administration & dosage*,  adverse effects
Chemical
Reg. No./Substance:
0/Anticoagulants; 81-81-2/Warfarin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The sphericity of the bearing surface in total hip arthroplasty.
Next Document:  Heterotopic ossification after uncemented hydroxyapatite-coated primary total hip arthroplasty.